SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-056941
Filing Date
2018-11-02
Accepted
2018-11-02 16:34:08
Documents
2
Period of Report
2018-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1531
2 EX-24 DOCUMENT attachment1.htm EX-24 3028
  Complete submission text file 0001209191-18-056941.txt   5927
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GLYCOMIMETICS, INC. 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879
Business Address
King Rachel K. (Reporting) CIK: 0001589712 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26770 | Film No.: 181157516